GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » CI US & Canada Lifeco Income ETF (TSX:FLI) » Definitions » Asset Impairment Charge

CI US & Canada Lifecoome ETF (TSX:FLI) Asset Impairment Charge : C$0.00 Mil (TTM As of Jun. 2014)


View and export this data going back to . Start your Free Trial

What is CI US & Canada Lifecoome ETF Asset Impairment Charge?

CI US & Canada Lifecoome ETF's Asset Impairment Charge for the three months ended in Jun. 2014 was C$0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2014 was C$0.00 Mil.

CI US & Canada Lifecoome ETF Asset Impairment Charge Historical Data

The historical data trend for CI US & Canada Lifecoome ETF's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CI US & Canada Lifecoome ETF Asset Impairment Charge Chart

CI US & Canada Lifecoome ETF Annual Data
Trend
Asset Impairment Charge

CI US & Canada Lifecoome ETF Quarterly Data
Dec13 Jun14
Asset Impairment Charge - -

CI US & Canada Lifecoome ETF Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

CI US & Canada Lifecoome ETF Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of CI US & Canada Lifecoome ETF's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

CI US & Canada Lifecoome ETF (TSX:FLI) Headlines

No Headlines